Clinical Trial Update: Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating adebrelimab in combination with chemotherapy as neoadjuvant therapy for resectable pancreatic cancer is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Jinling Hospital, China | Conditions: Pancreatic Cancer, Neoadjuvant Therapy | Phase 2 | Status: NOT_YET_RECRUITING